Nicky Karlen

Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma

A. Casadevall, B. Lau, D. Hanley, 2021, medRxiv.

Early Outpatient Treatment for Covid-19 with Convalescent Plasma

A. Casadevall, B. Lau, D. Hanley, 2022, The New England journal of medicine.

Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial

David M. Shade, A. Casadevall, B. Lau, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibody Correlates of Protection for COVID-19 Convalescent Plasma Associated with Reduced Outpatient Hospitalizations

A. Casadevall, B. Lau, L. Appel, 2023, medRxiv.

Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection

A. Casadevall, B. Lau, L. Appel, 2021, medRxiv.

Transfusion reactions associated with COVID‐19 convalescent plasma in outpatient clinical trials

David M. Shade, A. Casadevall, B. Lau, 2023, Transfusion.